INmune Bio (INMB)

• Market cap: $48.4M
• 1 day: 0%
• 5 days: 1.68%
• 1 month: -13.74%
• 3 months: -42.41%
• 6 months: -76.82%
• Year to date: -63.08%
• 1 year: -71.11%
• 5 years: -76.67%
• 10 years: -77.22%
• Sector: Healthcare
• Industry: Biotechnology

About: INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.

Employees: 13